On November 12th, Town Lake Loop Challenge Will Support Finding Home ATX, Austin’s Community-Led Initiative; FastestKnownTime (FKT) Route

AUSTIN, Texas – November 10, 2022 – (Newswire.com)

Finding Home ATX (https://findinghomeatx.org), a community-led initiative to end unsheltered homelessness, announced today that locals Charles Wagner and Michael Sabrin will run 100 or more miles on November 12 to raise a goal of $100,000 to support the initiative. The Town Lake Loop Challenge run will start at midnight on November 12 and the two runners plan to complete at least 10 loops of the 10-mile Ann and Roy Butler Hike and Bike Trail in 24 hours. Wagner and Sabrin plan to set a Fastest Known Time (https://fastestknowntime.com/route/town-lake-loop-challenge) record for the most loops ever run consecutively around Town Lake (Lady Bird Lake).

On any given night, Austin has over 3,000 unhoused men, women, and children. Finding Home ATX is a community-led, three-year, $515M initiative to end unsheltered homlessness in Austin. The initiative aims to house 3,000 unsheltered individuals, add 1,300 new units of affordable housing, and to build a more effective Homelessness Operating System. Major donors include the St. David’s Foundation, Indeed, City of Austin, Travis County, and several other corporations, foundations, and individuals.

“All of our community wants to get those living on our streets out of their tents and into homes with services,” said Austin Mayor Steve Adler. “Our community heroes are actually doing something to help get this done. The inspiring passion of Charles Wagner and Michael Sabrin, together with the generosity of their partners, is changing the lives of our unhoused neighbors — mile by mile. They are an example to us all.”

About the Runners

Charles Wagner is a father of two, UT Austin alum and software engineering executive at Indeed. He has made Austin his home for 20 years and though he started running during the pandemic, he’s now an avid runner. Michael Sabrin is also a father of two, a chef and product developer for Whole Foods Market. Michael attended the University of Georgia, where he was part of the UGA triathlon team. During their training runs logging thousands of miles on Austin’s streets and trails, Charles and Michael witnessed the growing impact of homelessness, and are grateful to use running to raise money and be part of the solution. 

Sponsors needed

$1,000/mile sponsorships are still available, and donations can be made at https://enca.st/TLC toward the $100,000 goal. During the run, our fundraising page will feature sponsor logos for the duration of miles supported, and we will feature sponsors on our social media pages during and leading up to the run. 
 

Who  Charles Wagner (Indeed) and Michael Sabrin (Whole Foods)
What  Running 100+ miles around Town Lake in 1 day
Why  End homelessness in Austin; set an FKT
When  November 12, 2022
Where  Ann and Roy Butler Hike and Bike Trail

Contact Information:

Leo Ramirez

Director of Development and Partnerships
leo@encast.co

512-961-6233

Press Release Service
by
Newswire.com

Original Source:

Two Austinites Announce Record-Setting 24-Hour, 100 Mile Run to End Austin Homelessness

LOS ALTOS, Calif. – November 10, 2022 – (Newswire.com)

 InterMed Resourc…

The post InterMed Resources and UroViu Corp Announce Agreement With HealthTrust Purchasing Group first appeared on Enrose Magazine.

The aesthetic device innovator’s partnership with Advalight builds on the company’s continued vision for global expansion and market development.

ADVATx
Combining the gold standard wavelength for eliminating vascular abnormalities with the new gold standard for non-ablative resurfacing, the ADVATx allows the provider to treat multiple FDA-cleared indications without the use of consumables.

LAS VEGAS – November 10, 2022 – (Newswire.com)

Reveal Lasers LLC, a wholly owned subsidiary of Reveal Lasers LTD, is pleased to announce their marketing and distribution agreement with Advalight, global manufacturers of the ADVATx device, the world’s only medical, solid-state laser producing both 589nm and 1319nm wavelengths. 

For Advalight, partnering with Reveal Lasers provides a proven and growing distribution team in North America to further launch ADVATx. This aligns with Advalight’s mission to grow the brand globally. With numerous FDA-cleared indications ranging from vascular abnormalities to acne, wrinkle reduction and warts, ADVATx has been adopted as the laser modality of choice for physicians dedicated to offering their patients the safest and most advanced laser solutions available. 

Travis Mahan, President of Advalight, stated, “Partnering with Reveal Lasers represents an important milestone in the growth of ADVATx in North America. The leadership team at Reveal has a demonstrated track record of successfully bringing groundbreaking technology like the ADVATx to the aesthetics market, and we are thrilled to pair our best-in-class technology with their world-class sales, marketing and practice support acumen.”

“Reveal Lasers is excited to partner with Advalight to further expand the reach of their ADVATx device in North America,” said Bob Daley, CEO of Reveal Lasers. “ADVATx is a global brand known around the world for its stellar manufacturing and superior clinical outcomes for patients and providers.” 

To learn more about Reveal Lasers LLC and ADVATx, visit us.reveallasers.com. 

About Reveal Lasers

Reveal Lasers LTD is a global leader in the innovation of minimally invasive cosmetic surgical procedures, medical treatments, and aesthetic solutions for providers and clinics. Born from a group of aesthetic industry veterans boasting over 50 years of collective industry experience, the company’s skills and expertise primarily encompass the development of energy Laser, Radiofrequency (RF), and Intense Pulse Light (IPL). The manufacturer ensures the uncompromising quality of products and the highest return on investment in the industry while committing to complete customer satisfaction by offering its partners a comprehensive support system for product implementation, marketing, and more.

About Advalight

Advalight is the company behind ADVATx and was founded in 2006 as a result of their founder’s Ph.D. studies at the Technical University of Denmark. The company is headquartered in Copenhagen, Denmark, and has a sales and service office in San Diego, CA, USA. ADVATx is available through our network of global distributors.

Contact Information:

Dean Fiacco

VP of Operations

dean.fiacco@reveallasers.com

(518)527-2558

Press Release Service
by
Newswire.com

Original Source:

Reveal Lasers Announces Distribution Agreement With Advalight

The post Reveal Lasers Announces Distribution Agreement With Advalight first appeared on Enrose Magazine.

The Covid-19 Detection Foundation (Dba Virufy) is the newest member of BARDA’S division of research, innovation, and ventures (DRIVe) medical countermeasures portfolio

Virufy

SAN FRANCISCO – November 10, 2022 – (Newswire.com)

Lessons learned from the COVID-19 pandemic underscore the need for more rapidly scalable, low-cost, and broadly available approaches in responding to public health emergencies. Digital tools like smartphone or web-based applications present opportunities for new classes of medical countermeasures that could complement traditional approaches. Aiming for easy detection of Covid-19, Virufy has created an IA-based app that should make the diagnosis of the disease more inclusive.

Through AI/ML algorithms, smartphone and computer applications can use images and audio captured with the phone or computer’s existing hardware to assess aspects of a person’s health. Health-related image and audio recordings contain much more information than the human eye or ear alone can process, but AI/ML algorithms could be used to process that information, detect differences and patterns among images and sounds, and identify disease signatures. These digital tools could empower individuals with actionable information about their infection status or acute skin condition and symptoms so that they can self-isolate and seek medical care if appropriate.

Virufy is developing an app that uses a few seconds of cough audio, collected through a smartphone or computer microphone, to identify cough patterns indicative of a current COVID-19 infection. Virufy has demonstrated this capability based on an analysis of several thousand samples from international clinical networks and through crowdsourcing. With DRIVe’s support, Virufy will conduct additional clinical studies to refine and test their algorithm. Virufy will also initiate proof-of-concept work on AI algorithms to screen for other respiratory diseases based on cough audio.

VisualDx aims to create an AI/ML algorithm that analyzes user-provided skin lesion images together with a symptom questionnaire on a smartphone app. The algorithm can provide information on the indicated disease and other similarly presenting conditions. If successful, this project would demonstrate the power of AI/ML-based image analysis for easily and rapidly accessible symptom checking for potentially any pox-based virus such as smallpox or monkeypox, and provide a digital health solution that could be modified easily in a future outbreak.

BARDA’s 2022-2026 Strategic Plan emphasizes the importance of preparing for future public health emergencies by collaborating with innovators to develop medical countermeasures that can help save lives. Cutting-edge, digital guidance tools that can pivot and be brought to scale in response to new threats could aid in public health response. These DRIVe projects, if successful, could demonstrate the power of these tools to rapidly respond to other threats such as influenza and smallpox.

These awards have been made under the Easy Broad Agency Announcement (EZ-BAA) area of interest (AOI) #9: Digital Medical Countermeasures.

This project has been funded in part with Federal funds from HHS/ASPR and BARDA, under Contract No. 75A50122C00034.

Contact Information:

Patricia Zylberman

PR Manager

patricia@sherlockcomms.com

+5511972447743

Press Release Service
by
Newswire.com

Original Source:

The Covid-19 Detection Foundation (Dba Virufy) and BARDA Announce Contract to Research & Develop Covid-19 Screening Through AI/Machine Learning Technology

The post The Covid-19 Detection Foundation (Dba Virufy) and BARDA Announce Contract to Research & Develop Covid-19 Screening Through AI/Machine Learning Technology first appeared on Enrose Magazine.

BOCA RATON, Fla. – November 10, 2022 – (Newswire.com)

ASP Isotopes Inc. …

The post ASP Isotopes Inc. Announces Pricing of Initial Public Offering and Nasdaq Listing first appeared on Enrose Magazine.

Beauty – Nu Woman Magazine originally published at Beauty – Nu Woman Magazine Beauty – Nu Woman Magazine originally published at Beauty – Nu Woman Magazine

Watch as Sabrina Carpenter gets ready for Vogue’s 130th anniversary event, Vogue World. Sabrina talks about how excited she is to kick off New York Fashion Week as a “local” New Yorker and gets into the details of her stunning black Alexandre Vaulthier dress. Watch the full Vogue World fashion show and runway experience here: […]

Stream every UEFA Champions League match live on Paramount+: Two of Europe’s most legendary clubs face off in

NEW HAVEN, Conn. – November 9, 2022 – (Newswire.com)

Amid the wave of se…

The post Statement on the Pediatric Surge From Federally Funded Pediatric Groups first appeared on Enrose Magazine.

ACDIS survey, sponsored by Iodine Software, examines what defines CDI program success, how CDI leaders view their team’s value, and what aspect of their program they would eliminate.

AUSTIN, Texas – November 9, 2022 – (Newswire.com)

Leading enterprise AI software provider Iodine Software today announced a national study of clinical documentation improvement (CDI) leaders that uncovers a number of key insights about how they view their roles and define CDI program success. The survey was conducted by the Association of Clinical Documentation Integrity Specialists (ACDIS) and sponsored by Iodine Software.

CDI programs are a critical component of every healthcare system’s revenue-cycle team, where clinical resources review medical record documentation for completeness and accuracy. 

Accurate and complete documentation is proven to increase earned reimbursement and reduce compliance risks for healthcare systems. If the clinical documentation is incomplete or unclear, CDI specialists query the provider prior to final claim submission to ensure accurate and complete billing, reducing costly and cumbersome issues that can arise during claims adjudication.

Given the ongoing revenue challenges presented by COVID-19 and other market forces, the study was conducted to understand how to best support CDI leaders as they manage their teams. 

The 2022 ACDIS CDI Leadership Council CDI Programmatics survey, which included surveys of 222 CDI leaders, found that nearly all CDI leaders (91%) track financial impact as a measure of departmental success, followed by 68% who use severity of illness (SOI) / risk of mortality (ROM) impact, and 53% who consider the observed-to-expected mortality rate. An additional 28% think observed-to-expected patient length of stay is an important metric that demonstrates CDI program success.

Additional key findings in the study include:

Measuring the Effectiveness of CDI Programs
According to the study, the four most-popular measures that identify CDI program effectiveness are:

• query rate (81%) 
• response rate (79%) 
• review rate (77%) 
• agreement rate (68%)

Most CDI Leaders Feel Valued – But Not All
Eighty-four percent (84%) of CDI leaders report that their program is valued internally by their hospital administrations; however, approximately one in 10 felt undervalued (~11%). In a recent virtual panel discussion, CDI leaders discussed why communicating the value of the CDI team is important. Additionally, these leaders indicated a need to support the CDI team by providing personal feedback to individual team members and department score cards that highlight achieved outcomes.

Optimizing Performance: CDI Leaders’ Challenges to Achieving Top Performance
Respondents to the ACDIS survey reported that the biggest barrier to their CDI team reaching peak performance is a lack of staffing resources (36%), followed by physician engagement challenges (22%) and a lack of technology resources (18%). An additional 9% felt that organization priorities are not aligned properly. 

Staffing challenges have persisted in the CDI profession, as workforce shortages, budget gaps and fierce competition for talent continue to plague the industry. Physician engagement also has historically been a challenge for CDI, because stretched providers often experience significant administrative burdens that result in frustration and burnout. In recent years, physician query and AI-driven CDI tool platforms have played central roles in supporting CDI team performance to drive greater efficiency, reduce workload and drive provider engagement.

Supporting CDI to Work More Efficiently: What CDI Duties Are Most Cumbersome?
While CDI is critical to the financial health of every healthcare system, the role can include extremely tedious tasks that contribute to CDI burnout. In the ACDIS leadership survey, CDI leaders outlined what aspects of the workflow they would eliminate if they could. The number-one responsibility named varied greatly and included, in order:

1. 49%: Wasting time reviewing cases without opportunity
2. 20%: Tracking down physician responses
3. 9%: Working DRG predictions

To help reduce the burdens presented by these and other listed duties, many CDI leaders are implementing in-house and third-party technology solutions that better engage providers and identify a prioritized worklist of cases to review. These CDI tools also leverage new technology that automates and augments clinical human resources and are becoming increasingly important as more work is performed virtually instead of within hospital walls.

“Based on our experience working with nearly 1,000 of the top hospitals in the U.S., Iodine Software deeply understands the market forces affecting the CDI industry, so we know they are under pressure to work more efficiently and capture more earned revenue for a hospital’s bottom line,” said Iodine Software Co-founder and CEO William Chan. “This study reinforces the need for AI-backed solutions that augment the great work that CDI specialists perform every day.”

ACDIS discussed the study’s findings with participants from dozens of provider organizations in September. The full report also is available to download.

About Iodine Software

Iodine is an enterprise AI company that is championing a radical rethink of how to create value for healthcare professionals, leaders, and their organizations: automating complex clinical tasks, generating insights and empowering intelligent care. Iodine’s powerful predictive engine complements the skills and judgment of healthcare professionals by interpreting raw clinical data to generate real-time, highly focused, predictive insights that clinicians and hospital administrators can leverage to dramatically augment the management of care delivery – facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com.

PR Contact: 
press@iodinesoftware.com

Contact Information:

Amanda Wratchford

VP of Marketing

awratchford@iodinesoftware.com

9042522156

Press Release Service
by
Newswire.com

Original Source:

National Study of Clinical Documentation Improvement Leaders Finds Measuring Financial Impact for Their Provider Organization is Most Important Metric of Success

The post National Study of Clinical Documentation Improvement Leaders Finds Measuring Financial Impact for Their Provider Organization is Most Important Metric of Success first appeared on Enrose Magazine.